Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?-Reference-Cited by-同舟云学术

Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?

Published:2016-06-19 Issue:10 Volume:30 Page:1629-1637
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Boettiger David C.,Sabin Caroline A.,Grulich Andrew,Ryom Lene,Bonnet Fabrice,Reiss Peter,Monforte Antonella d’arminio,Kirk Ole,Phillips Andrew,Bower Mark,Fätkenheuer Gerd,Lundgren Jens D.,Law Matthew

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference50 articles.

1. Anti-HIV drugs for cancer therapeutics: back to the future?;Chow;Lancet Oncol,2009

2. Insights into the broad cellular effects of nelfinavir and the HIV protease inhibitors supporting their role in cancer treatment and prevention;Gantt;Curr Opin Oncol,2013

3. Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo;Gills;Clin Cancer Res,2007

4. Nelfinavir augments proteasome inhibition by bortezomib in myeloma cells and overcomes bortezomib and carfilzomib resistance;Kraus;Blood Cancer J,2013

5. Selective inhibition of HER2-positive breast cancer cells by the HIV protease inhibitor nelfinavir;Shim;J Natl Cancer Inst,2012

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PIs versus NNRTIs and the Risk of Cancer among People with HIV;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-04-23

2. Compound‐ and Class‐Specific Limits for Common Impurities in Pharmaceuticals;Mutagenic Impurities;2021-12-08

3. Oral administration of tipranavir with long-chain triglyceride results in moderate intestinal lymph targeting but no efficient delivery to HIV-1 reservoir in mesenteric lymph nodes;International Journal of Pharmaceutics;2021-06

4. HIV‐1, HAART and cancer: A complex relationship;International Journal of Cancer;2020-05-15

5. Immunosenescence and Ageing in HIV;Handbook of Immunosenescence;2019